LONDON, 01 March 2013 – Panmure Gordon & Co., a leading independent institutional stockbroker and investment bank, is pleased to advise that it acted as broker to e-Therapeutics plc on a £40m fundraise through an accelerated placing.

e-Therapeutics is a drug discovery and development company.  The fundraising enables the company to advance its lead cancer drug and exploit its network pharmacology platform.